Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Two Vildagliptin + Metformin Fixed-Dose Combination Tablets Under Fed Conditions in Healthy Thai Subjects
TCTR20240908005Phase 1Unknown
- Sponsor
- SciGen Ltd
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of vildagliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by SciGen Ltd. Status: unknown.
02
Drugs
vildagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20240908005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240908005.